No HR professional is exempt from the planning.
Take the work out of creating and maintaining an employee handbook.
SHRM Seminars will host HR education every month in San Francisco this fall! Select the program that meets both your scheduling and development needs.
Join us, September 27 - 28.
Study raises issues about health savings accounts and Rx drugs
last updated 5/8/2014
Using data from a large U.S. employer that fully replaced traditional managed-care health insurance with a high-deductible health plan linked to employee
health savings accounts (HSAs), new research from the nonprofit Employee Benefit Research Institute (EBRI) found that the move to the HSA-eligible plan reduced the number of generic and brand-name prescriptions filled. Some HSA advocates, however, raised issues with the findings.
Funds contributed into an HSA on a pretax basis—whether by employees or their employer—can be used to pay for most prescription drug costs paid out-of-pocket by employees, but not for over-the-counter medications except for diabetes supplies and some other
EBRI reported that, at the end of a four-year period following the adoption of the full replaced HSA plan at the unnamed large employer, the use of generic drugs instead of more expensive brand-name medications had increased by 4.5 percentage points for hypertension, 15.4 percentage points for dyslipidemia (fat levels in blood), and 7.8 percentage points for asthma/chronic obstructive pulmonary disease (COPD). No significant effects were detected for diabetes prescriptions.
However, the EBRI report also noted that generic drug rates, or GDRs, can rise if the number of filled brand-name prescriptions decreases, whether or not the brand-name drug is replaced with a generic version. After adopting the HSA plan, the study found that higher GDRs in the case study were largely achieved due to individuals discontinuing use of brand-name drugs without substituting generic alternatives.
The full report, “Brand-Name and Generic Prescription Drug Use After Adoption of a Full-Replacement, Consumer-Directed Health Plan With a Health Savings Account,” was published in
the March 2014 issue of
HSAs and Rx Coverage: Common Misperceptions
Kevin McKechnie, executive director of the American Bankers Association's
HSA Council, told
SHRM Online in an interview that people who shift to HSA-qualified plans tend to move strongly into generic drugs rather than discontinue taking needed medication, and he raised issues with EBRI's methodology "with respect to the conclusions drawn, which is to say its reliance on findings from a case study focused on one employer" in an undisclosed industry.
McKechnie also addressed what he called a common misperception about the ability of high-deductible, HSA-linked plans to cover prescription drugs outside of the deductible. "To the extent that an insurer considers a prescription drug preventative in nature, you can offer those drugs with no cost sharing, outside of the deductible. It's not something plans are required to do, however." As an example, he pointed out
this drug formulary for HSA-compliant high-deductible plans offered by Blue Cross of Idaho.
"This is just one area in which there seems to be a great deal of misunderstanding," McKechnie added. "If you look at the formularies of certain plans, you'll see [that] drugs for chronic conditions, such as high blood pressure or high cholesterol, are considered preventative medications excluded in whole or part from the deductible. But it's not done in all cases."
Many people would like to see those kinds of drugs required to be covered on a first-dollar basis, he noted, "but that necessarily makes plans more expensive."
Plans that require all drugs and most procedures to be covered subject to cost sharing—paid for by employees under the deductible—have lower premiums, he explained, "but it does require plan members to be more judicious in how they spend their dollars," which need not be a negative outcome.
However Paul Fronstin, director of EBRI’s Health Education and Research Program and author of the report, noted
on EBRI's website that, based on the report's findings, sponsors of HSA-linked health plans may want to have maintenance medications deemed as preventive and treated as exempt from the deductible. “Although lower prescription-drug use can save pharmacy costs for plan sponsors, it could also result in even higher downstream medical costs if people stop taking maintenance drugs for chronic diseases,” Fronstin said.
First-Dollar Coverage for Preventative Care
The issue of allowing first-dollar insurance coverage for HSA-compliant high-deductible health plans (HDHPs) also is addressed in a May 2014 report from the University of Michigan’s Center for value-Based Insurance Design. The report,
Health Savings Account-Eligible High-Deductible Health Plans: Updating the Definition of Prevention, notes that
IRS Notice 2004-50 offers guidance on preventive care prescription drug benefits allowable by an HSA-qualified HDHP without satisfying the minimum deductible requirement. For instance, question and answers 26 and 27 of Notice 2004-50 state:
Solely for this purpose, drugs or medications are preventive care when taken by a person who has developed risk factors for a disease that has not yet manifested itself or not yet become clinically apparent (i.e., asymptomatic), or to prevent the reoccurrence of a disease from which a person has recovered. For example, the treatment of high cholesterol with cholesterol-lowering medications (e.g., statins) to prevent heart disease or the treatment of recovered heart attack or stroke victims with Angiotensin-converting Enzyme (ACE) inhibitors to prevent a reoccurrence, constitute preventive care. In addition, drugs or medications used as part of procedures providing preventive care services specified in Notice 2004-23, including obesity weight-loss and tobacco cessation programs, are also preventive care. However, the preventive care safe harbor under section 223(c)(2)(C) does not include any service or benefit intended to treat an existing illness, injury, or condition, including drugs or medications used to treat an existing illness, injury or condition.
Stephen Miller, CEBS, is an online editor/manager for SHRM.
You have successfully saved this page as a bookmark.
Please confirm that you want to proceed with deleting bookmark.
You have successfully removed bookmark.
Please log in as a SHRM member before saving bookmarks.
Please purchase a SHRM membership before saving bookmarks.
An error has occurred
Recommended for you
The application deadline is October 21
SHRM’s HR Vendor Directory contains over 3,200 companies